Just like teenagers complain that their parents don’t let them be, it’s expected that medical device and other biomedical companies will complain that the U.S. Food and Drug Administration (FDA) slows them down. But it may be more serious than that. Timothy Hay reports in the Venture Capital Dispatch blog of The Wall Street Journal [...]